Disc Medicine, Inc. (IRON)

USD 63.5

(-2.31%)

Market Cap (In USD)

1.88 Billion

Revenue (In USD)

-

Net Income (In USD)

-76.42 Million

Avg. Volume

251.06 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
25.6-77.6
PE
-
EPS
-
Beta Value
0.18197386
ISIN
US2546041011
CUSIP
CIK
1901203
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. John D. Quisel Esq., J.D., Ph.D.
Employee Count
-
Website
https://www.discmedicine.com
Ipo Date
2020-08-12
Details
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.